✦ LIBER ✦

314 Biomarker Analysis in the First-in-human OMP-59R5 (anti-Notch2/3) Phase I Study Demonstrates Pharmacodynamic (PD) Modulation of the Notch Pathway in Patients with Advanced Solid Tumors

✍ Scribed by Tolcher, A.; Kapoun, A.M.; Wang, M.; Zhang, C.; Patnaik, A.; Papadopoulos, K.; Chugh, R.; Thorpe, V.; Dupont, J.; Smith, D.C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

28 A First-in-human Phase I Study to Eva

✍ Smith, D.C.; Chugh, R.; Patnaik, A.; Papadopoulos, K.; Chambers, G.; Thorpe, V.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 75 KB

619 Results of the First-in-human Phase

✍ Cervantes, A.; Saura, C.; Roda, D.; Dienstmann, R.; Rosello, S.; Carles, J.; Fun 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

A phase I pharmacokinetic (PK) and seria

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 256 KB